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The 6-hydroxy-D-nicotine oxidase gene of Arthrobacter oxidans was cloned into E.coli with the aid of the 
expression vector pKK223-3. This enzyme, as well as the E.coli enzymes succinate dehydrogenase and fu- 
marate reductase, bears the cofactor FAD covalently attached to the polypeptide through a His-N,-8a-link- 
age. The amino acid sequence surrounding the histidine residue involved in FAD binding in 6-hydroxy-D- 
nicotine oxidase and the two E.coli enzymes, however, show no homology. Nevertheless, 6-hydroxy-D-nico- 
tine oxidase is expressed in E.coIi in vivo and in an E.coli-derived coupled transcription-translation system 
as a covalently flavinylated, enzymatically active polypeptide. 
(Arthrobacter oxidans) 6-Hydroxy-D-nicotine oxidase CovalentfTavinylation Coupled transcription-translation 
1. INTRODUCTION 
Several flavoenzymes of prokaryotic as well as 
of eukaryotic origin are known to contain the 
flavin moiety covalently bound to the enzyme [l]. 
The mechanism of flavin attachment, enzyme 
catalyzed or nonenzymatic, is still a matter of 
dispute [2] and the functional sigificance of this 
type of binding is not obvious [ 11. In the E. coli en- 
zymes SDH and FR, 2 genetically closely related 
proteins [3], the covalent bond is formed between 
the &methyl group of the isoalloxazine ring of 
FAD and the NJ of histidine [4]. In 6-HDNO from 
Arthrobacter oxidans we have the same type of 
binding but the amino acid sequence of the FAD- 
binding peptide is different [5]. The question of 
whether the covalent binding of FAD is dependent 
Abbreviations: 6-HDNO, 6-hydroxy-D-nicotine ox- 
idase; SDH, succinate dehydrogenase; FR, fumarate 
reductase; DNBD, dinucleotide-binding domain; kb, 
kilobases 
on the recognition by a specific enzyme of a certain 
amino acid sequence surrounding the histidine 
residue to be flavinylated was approached by clon- 
ing the 6-HDNO gene into E. coli [6] and an at- 
tempt to express an enzymatically active, covalent- 
ly flavinylated polypeptide. Here we show, to our 
knowledge for the first time, that an enzyme with 
an amino acid sequence of the flavin peptide dif- 
ferent from that of the E. coli enzymes SDH and 
FR is Imade in vivo and in an in vitro coupled 
transcription-translation system as an enzymatical- 
ly active, covalently flavinylated polypeptide. 
2. MATERIALS AND METHODS 
[14C]Riboflavin was purchased from Amersham 
Buchler, Braunschweig, [14C]FAD was prepared as 
described by Briihmiiller and Decker [7]. Protein 
A-Sepharose was from Pharmacia, Freiburg i.Br.; 
restriction endonucleases were obtained from 
Boehringer, Mannheim. The 6-HDNO gene was 
cloned as a 2.8 kb EcoRI-Hind111 DNA restriction 
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fragment derived from pAO1 [6] and inserted into 
the corresponding restriction sites of pKK223-3 [8] 
giving rise to pDB221. pKK223-3 is a derivative of 
pBR322 carrying the tat promoter in front of a 
polylinker sequence. Expression of 6-HDNO in 
pDB221 most probably starts from the tat pro- 
moter (not shown). E. coli HBlOl [9] was used as 
host strain. pDB 221 and pBR322 DNA was pre- 
pared and purified on CsCl gradients according to 
191. 
[14C]Riboflavin labeling of A. oxidans and E. 
coli whole cells was done according to Hederstedt 
[lo]. Cell-free extracts of labelled cells were pre- 
cipitated with 6-HDNO-specific antiserum coupled 
to protein A-Sepharose [ 111. The precipitated pep- 
tides were separated on 7.5% polyacrylamide gels, 
fixed, stained and prepared for fluorography. 6- 
HDNO activity in transformed E. coli HBlOl cells 
was determined spectrophotometrically [ 121. 
pDB221 and pBR322 DNA was used to prime an 
E. coli-derived in vitro coupled transcription- 
translation system as described by Miiller and 
Blobel [ 131. In vitro synthesized polypeptides were 
labelled with [35S]methionine, precipitated with 
6-HDNO antiserum and analysed on lo-15070 
polyacrylamide gradient gels, followed by fluoro- 
graphy. 6-HDNO activity synthesized in the coupl- 
ed transcription-translation system was immuno- 
precipitated from ten 25~1 assays with protein A- 
Sepharose-bound antiserum. The bound 6-HDNO 
activity was determined by luminol-mediated 
chemiluminescence as described by Hinkkanen et 
al. [14]. [14C]FAD incorporation into in vitro- 
made polypeptides was measured on the immuno- 
precipitates obtained as described above, syn- 
thesized in the presence of 1 PM [14C]FAD. The 
immunocomplex was dissociated by boiling in 
PAGE sample buffer and the protein-bound 
radioactivity determined in a liquid scintillation 
counter. 
oxidans cells with the FAD precursor [14C]ribo- 
flavin and precipitated cell-free extracts obtained 
from these cells with 6-HDNO-specific antiserum. 
Although E. coli cells take up [‘4C]riboflavin very 
poorly, they were sufficiently labelled to identify 
by immunoprecipitation one labelled polypeptide 
in cells harbouring pDB221, but not pBR322 
(fig.1, lanes 2 and 3). From A. oxiduns cells 2 
labelled polypeptides were precipitated (fig. 1, lane 
1); the major band of 48 kDa corresponds to 
6-HDNO [ 151 and a second one of approx. 70 kDa. 
The labelled polypeptide identified in E. coli cells 
has an apparent molecular mass of 52 kDa and, 
thus is about 4 kDa larger than the authentic 
6-HDNO made by A. oxidans. The significance of 
the coprecipitated 70 kDa polypeptide in A. ox- 
idans in relation to 6-HDNO as well as the expres- 
sion of the 6-HDNO gene in E. coli as a larger 
polypeptide are currently under investigation. The 




3. RESULTS AND DISCUSSION 123 
In pDB221-transformed E. coli HBlOl cells the 
specific 6-HDNO activity is apout 60 mU as com- 
pared to approx. 80 mU/mg in DL-nicotine- 
induced A. oxidans cells. Is this 6-HDNO syn- 
thesized in E. cofi HBlOl cells also covalently 
flavinylated? To answer this question we labelled 
E. coli cells harbouring pDB221 or pBR322 and A. 
Fig.1. In vivo [ 14C]riboflavin-labelled polypeptides 
precipitated with 6-HDNO-specific antiserum from: (1) 
A. oxiduns cells, (2) E. coli HBlOl cells harbouring the 
recombinant plasmid pDB221, (3) E. co/i HBlOl cells 
harbouring pBR322.D, 6-HDNO from A. oxidans; ED, 
labelled polypeptide precipitated from E. coli cells; X, 
unidentified coprecipitated labelled polypeptide. 
- 55.4 
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flavinylated since fixing of the polyacrylamide gels 
in acetic acid and treatment for fluorography 
removes noncovalently bound FAD [lo]. 
When the [35S]methionine-labelled polypeptides 
synthesized in an E. coli coupled transcription- 
translation system primed with pDB221 were com- 
pared to those synthesized with pBR322, one ma- 
jor additional polypeptide of approx. 52 kDa was 
synthesized in the pDB221-primed assays (fig.2A). 
No polypeptide was precipitated with 6-HDNO- 
specific antiserum from pBR322-primed assays 
(fig.2B, lane l), but from pDB221 assays the 52 
kDa polypeptide was recovered (fig.2B, lane 2). 
The coprecipitated low molecular mass material 
probably represents run-off products. Antibody- 
bound 6-HDNO is enzymatically active [14]. Im- 
munoprecipitated from in vitro assays and bound 
to protein A-Sepharose it can be used directly for 
the determination of enzyme activity. Only 
A 
36.5-- 
Fig.2. [35S]Methionine-labelled polypeptides ynthesized 
in an E. co&derived coupled transcription-translation 
system and analyzed by PAGE. (A) Total labelled 
polypeptides: (1) pBR322-primed system, (2) pDB221- 
primed system. (B) Polypeptides precipitated with 
6-HDNO-specific antiserum from pBR322 (l)- and 
pDB221 (2)-primed systems. (b) tet-gene product, (D) 
&lactamase gene product. Arrow indicates 52 kDa poly- 
peptide. Molecular mass standards are indicated in kDa. 
time [mini 
Fig.3. Luminometric determination of 6-HDNO activity 
in an E. coli-derived coupled transcription-translation 
assay. (- ) pDB221-primed assays, (-- -) pBR322- 




Fig.4. [14C]FAD binding and 6-HDNO activity in E. 
co/i-derived coupled transcription-translation assays. (1) 
Assays primed with pBR322, (2) assays primed with 
pDB221. (A) Enzyme activity, (bars) bound [14C]FAD. 
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I II 
DM3D covalent attachment side 
snq3] Gly-X-Gly-X-X-Gly . . . . . . . . . . . Lys-Val-Phe-I'ro-Thr-Arg-Ser-tlis-~hr-V~l-Ser-Ala - 
FR fl 7) Gly-X-Gly-X-X-Gly . . . . . . . . . . . Lys-Val-Tyr-Pro-blet-Ar~-Ser-tlis-lhr-Val-Ala-Ala - 
6-HDNO [S] ? Ser-Gly-Gly-Asn-.~sn-Pro-Asp-His-Tyr-Gln-Pro-Ala - 
ORk6-j Xh-Xh-Gly-X-Gly . . . . . . . . . . .I.ys-Val-His-Pro-Asn-Se~-Val-!lis-Ile-Cys-Ala-Val 
Fig.5. Comparison of the FAD-binding domains of different enzymes. 
pDB221-primed transcription-translation assays 
produced 6-HDNO activity (fig.3). When [14C]FAD 
was added to these assays, protein-bound label was 
coprecipitated with 6-HDNO activity by 6-HDNO 
antiserum (fig.4). This means that not only in vivo 
E. cofi HBlOl cells harbouring pDB221, but also 
in the in vitro transcription-translation system, 
6-HDNO was made as an enzymatically active, 
covalently flavinylated polypeptide. 
Our results are the first indication that it is possi- 
ble to express in a heterologous system the same 
covalently flavinylated enzyme as in the organism 
of origin. A comparison of the amino acid se- 
quences of the FAD-binding peptide of 6-HDNO 
and the corresponding domains of SDH and FR 
from E. coii shows no obvious homology, with the 
exception of the common His residue involved in 
the covalent FAD binding (fig.5). In general, no 
amino acid sequence homology was found between 
the FAD peptides of various origin [l]. On the 
other hand, NADPH-dependent cytochrome 
P-450 oxidoreductase, cloned into E. coli, was 
shown to possess strong homologies in the FAD- 
binding domain to SDH and FR [16], yet carries 
the cofactor noncovalently bound. It differs, 
however, in the DNBD from SDH and FR ([ 181, 
table 1). These findings argue, in our opinion, 
against an enzymatic mechanism of covalent 
flavinylation. We consider, however, as a prere- 
quisite for such a type of binding the presence of 
the DNBD Gly-X-Gly-X-X-Gly- at the N-terminal 
part of the protein. The cofactor first bound to this 
domain is later on attached cotranslationally [l], 
covalently or noncovalently, tp the protein, depen- 
ding on the presence of a histidine residue placed 
in the right position [l]. The prediction of this 
hypothesis is that 6-HDNO, as well as all other en- 
zymes with covalently bound FAD, should exhibit 
at their N-terminal part the dinucleotide-binding 
consensus sequence mentioned above. The estab- 
lishment of the nucleotide sequence of the 6- 
HDNO gene, currently in progress, will provide an 
answer to this assumption. 
ACKNOWLEDGEMENTS 
We wish to thank Professor K. Decker for 
valuable suggestions and for critical reading of the 
manuscript. This work was supported by a grant 
from the Deutsche Forschungsgemeinschaft, 
Bonn, through SFB 206. 
REFERENCES 











(Massey, V. and Williams, C.H. eds) pp. 465-472, 
Elsevier, Amsterdam, New York. 
Magnusson, K., Hederstedt, L. and Rutberg, L. 
(1985) J. Bacterial. 162, 1180-1185. 
Wood, D., Darlison, M.G., Wilde, R. J. and Guest, 
R. (1984) Biochem. J. 222, 519-534. 
Singer, T.P., Kearney, G.B. and Massey, V. (1955) 
Arch. Biochem. Biophys. 60, 255-257. 
Briihmiiller, M. and Decker, K. (1973) Eur. J. Bio- 
them. 37, 256-258. 
Brandsch, R. (1984) in: Flavins and Flavoproteins 
(Bray, R.C. et al. eds) pp. 815-818, De Gruyter, 
Berlin. 
Briihmiiller, M. and Decker, K. (1976) Anal. 
Biochem. 71, 550-554. 
Ammon, E., Brosius, J. and Ptashne, M. (1983) 
Gene 25, 167-178. 
Maniatis, T., Fritsch, E.F. and Sambrook, J. 
(1982) Molecular Cloning, Cold Spring Harbor 
Laboratory, NY. 
Hederstedt, L. (1983) Eur. J. Biochem. 132, 
589-593. 
Flurkey, W.H. and Kolattukudy, P.E. (1981) Arch. 
Biochem. Biophys. 212, 154-161. 
207 
Volume 192, number 2 FEBS LETTERS November 1985 
[12] Decker, K. and Dai, V.D. (1%7) Eur. J. Biochem. 
3, 132-138. 
[13] Mtiller, M. and Blobel, G. (1984)Proc. Natl. Acad. 
Sci. USA 81, 7421-7425. 
[14] Hinkkanen, A., Maly, F.-E. and Decker, K. (1983) 
Hoppe-Seyler’s Z. Physiol. Chem. 364, 407-412. 
[15] Hinkkanen, A., Lilius, E.-M., Nowack, J., Maas, 
R. and Decker, K. (1983) Hoppe-Seyler’s Z. 
Physiol. Chem. 364, 801-806. 
[16] Porter, T.D. and Kasper, C.D. (1985) Proc. Natl. 
Acad. Sci. USA 82, 973-977. 
[17] Cole, S. (1982) Eur. J. Biochem. 122, 479-484. 
[18] Moller, W. and Amons, R. (1985) FEBS Lett. 186, 
l-7. 
208 
